Cargando…
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
Lysosomal storage diseases (LSDs) are rare inherited metabolic disorders characterized by a dysfunction in lysosomes, leading to waste material accumulation and severe organ damage. Enzyme replacement therapy (ERT) and haematopoietic stem cell transplant (HSCT) have been exploited as potential treat...
Autores principales: | Penati, Rachele, Fumagalli, Francesca, Calbi, Valeria, Bernardo, Maria Ester, Aiuti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500670/ https://www.ncbi.nlm.nih.gov/pubmed/28560469 http://dx.doi.org/10.1007/s10545-017-0052-4 |
Ejemplares similares
-
MtDNA-maintenance defects: syndromes and genes
por: Viscomi, Carlo, et al.
Publicado: (2017) -
Amino acid synthesis deficiencies
por: de Koning, T. J.
Publicado: (2017) -
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
por: Baruteau, Julien, et al.
Publicado: (2017) -
Preserving Ambulation in a Gene Therapy-Treated Girl Affected by Metachromatic Leukodystrophy: A Case Report
por: Faccioli, Silvia, et al.
Publicado: (2023) -
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies
por: Aerts, Johannes M. F. G., et al.
Publicado: (2011)